C

Codexis
D

CDXS

4.60500
USD
0.27
(6.23%)
Market Closed
Volume
13,775
EPS
-1
Div Yield
-
P/E
-5
Market Cap
374,745,022
OverviewSignalsIdeasNews
Related Instruments
    CI
    CI
    -2.54
    (-0.78%)
    321.53 USD
    D
    DRI
    -1.800
    (-1.07%)
    166.890 USD
    ECL
    ECL
    -2.380
    (-0.96%)
    245.230 USD
    FDX
    FDX
    2.21
    (0.76%)
    294.44 USD
    KR
    KR
    -1.050
    (-1.78%)
    58.040 USD
    LEN
    LEN
    -0.890
    (-0.52%)
    168.900 USD
    MCD
    MCD
    -6.07
    (-2.03%)
    290.22 USD
    ORCL
    ORCL
    -3.380
    (-1.81%)
    192.27 USD
    TJX
    TJX
    0.050
    (0.04%)
    121.46 USD
    TRV
    TRV
    4.27
    (1.66%)
    260.75 USD
    More
News

Title: Codexis

Sector: Healthcare
Industry: Biotechnology
Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products, leveraging its proprietary CodeEvolver directed evolution technology platform. The firm's products and services include Biocatalysts and Enzymes. The company generates majority of its revenue through product sales and also licenses its technology platform CodeEvolver to pharmaceutical companies enabling them to use this technology, in-house, to engineer enzymes for their own businesses. Geographically, it derives revenue from the United States, Ireland, Switzerland, China and other markets.